Current approved therapeutic strategies for IPF and LC treatment
By A Mystery Man Writer
Description
![Current approved therapeutic strategies for IPF and LC treatment](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-14344-7/MediaObjects/41467_2020_14344_Fig1_HTML.png)
Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis
![Current approved therapeutic strategies for IPF and LC treatment](https://www.frontiersin.org/files/Articles/1032355/fimmu-14-1032355-HTML-r2/image_m/fimmu-14-1032355-g001.jpg)
Frontiers Potential targeted therapy based on deep insight into the relationship between the pulmonary microbiota and immune regulation in lung fibrosis
![Current approved therapeutic strategies for IPF and LC treatment](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2018/nejm_2018.378.issue-19/nejmra1705751/20180510/images/img_medium/nejmra1705751_f2.jpeg)
Idiopathic Pulmonary Fibrosis
Pliant Therapeutics Announces Positive Data from the
![Current approved therapeutic strategies for IPF and LC treatment](https://www.researchgate.net/publication/359634242/figure/fig1/AS:11431281187925787@1694451005317/Study-algorithm-COVID-19-coronavirus-disease-2019-RICU-respiratory-intensive-care_Q320.jpg)
Roberto TONELLI, Professor (Assistant), MD PhD
![Current approved therapeutic strategies for IPF and LC treatment](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-14-00819/article_deploy/html/images/pharmaceuticals-14-00819-ag-550.jpg?1629459964)
Pharmaceuticals, Free Full-Text
![Current approved therapeutic strategies for IPF and LC treatment](https://onlinelibrary.wiley.com/cms/asset/89d6990d-ba95-433e-ab67-ef57f5781592/mco274-fig-0001-m.jpg)
Current therapeutic strategies for respiratory diseases using mesenchymal stem cells - Wang - 2021 - MedComm - Wiley Online Library
![Current approved therapeutic strategies for IPF and LC treatment](https://i1.rgstatic.net/ii/profile.image/11431281180406106-1691590099104_Q512/Roberto-Tonelli-3.jpg)
Roberto TONELLI, Professor (Assistant), MD PhD
![Current approved therapeutic strategies for IPF and LC treatment](https://www.researchgate.net/publication/378089947/figure/fig4/AS:11431281222967443@1707485684187/figure-fig4_Q320.jpg)
Enrico CLINI, Professor in Respiratory Medicine
from
per adult (price varies by group size)